Biotechnology

Growth hormone transgenic Coho salmon exhibit significantly greater growth rates than selectively bred Coho salmon, in a variety of production conditions and experimental designs, according to emerging research from the Pacific Science Enterprise Centre.

Seafood that has been produced in laboratories directly from fish cells could be worth more than the lab-grown or plant-based meat in time, with a $1 trillion market ready to be exploited.

Alexia Akbay, founder and CEO of seaweed farming start-up Symbrosia, explains to The Fish Site how the company aims to both reduce the carbon footprint and improve the productivity of ruminant livestock agriculture.

Despite a number of challenges that still need to be overcome, genome sequencing has a growing range of practical applications in aquaculture and, as costs come down, it is going to be increasingly widely used.

Shrimp producers are going to have to embrace new technologies and production techniques if they are going survive, according to Rabobank’s senior seafood analyst Gorjan Nikolik.

Wider application of genetic improvement in aquaculture, with a focus on selective breeding, will help boost seafood production without the need to hugely increase the volume of inputs – including feed, land and water – required by the sector.

The Aquaculture Innovation Showcase is coming in September. Ahead of the event in London, The Fish Site spoke to TransAlgae’s VP of research and development, Ofra Chen, to discuss how algae can revolutionise the health and nutrition of farmed fish.

Mike Selden, CEO of Finless Foods, explains how cell-based seafood can complement conventional aquaculture in helping to feed the planet without destroying ocean life.

In this two-part feature, The Fish Site and Mike Selden, CEO of the cell-based fish company Finless Foods, discuss the background of lab-grown fish and the origins of Finless Foods bluefin tuna.

Salmon rendered sterile through gene editing are exhibiting encouraging behaviour and performance during the grow-out phase, according to new research results.

Ways to commercialise the production of finfish rendered sterile by novel methods sparked a thought-provoking discussion at the end of the inaugural International Finfish Sterility Workshop, which was held in Stirling this week.

In the second part of the feature, Professor Ross Houston, who is currently involved in using gene editing to improve resistance to diseases in salmon, explains the barriers – technical, regulatory and ethical – that need to be overcome before such techniques …